Leonteq Securities AG’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Leonteq Securities AG's BEAM Position: Q2 2026 in Review
Leonteq Securities AG increased its Beam Therapeutics (BEAM) stake by 126% in Q2 2026, buying an estimated $470K and bringing the position to 27,926 shares worth $958K. The position accounts for 0.03% of the portfolio, ranked #266.
Leonteq Securities AG first reported a position in BEAM in Q4 2020 and has held it in 17 quarters since. 275 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Leonteq Securities AG held 27,926 shares of Beam Therapeutics worth $958K as of Q2 2026.
- Leonteq Securities AG bought 15,559 Beam Therapeutics shares in Q2 2026, an estimated $470K.
- Beam Therapeutics made up 0.03% of Leonteq Securities AG's portfolio in Q2 2026, its #266 holding.
- Leonteq Securities AG first reported a position in Beam Therapeutics in Q4 2020 and has held it in 17 quarters since.
- 275 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.